About us
Passionate about helping people through tech
Founder's story
Why The founders got involved
Neurological diseases are in our families, so it was a heart decision in combination with our background that gave us the skills to found ZenzeTech. It is when meeting the patients that it all makes sense to us. They are like our second family, you always feel welcome, and it is a heart-warming experience. Ultimately, to improve their quality of life would make us very happy and proud
Christian and Magdalena will be back shortly in a video, talking about purpose, values and culture – stay tuned!

MEET OUR TEAM
Board of directors
ZenzeTech
Mission & Vision

the vision
a future where neurological diseases are better understood, diagnosed and treated
ZenzeTech envision a future where data and AI play a natural part of clinical decision making as a partner to caregivers and patients. We strive to provide a common understanding, enabling earlier diagnostics and personalised treatment
the mission
Helping people with neurological diseases to a better quality of life
Through development of novel technologies combined into non-invasive solutions that are easy to use and developed in collaboration with stakeholders in healthcare to create value for patients, caregivers, and society

Values
We work to
Company timeline

Receiving a grant from Tuborgfondet and The Fund For Entrepreneurship for addressing SDG 3. The grant was used to build the first prototype

We founded the company in September 2020 and got a flying start with the first angel investment and two grants from The Danish Innovation Fund

+120 companies applied for the accelerator 'Danish Tech Challenge', 20 were selected and in the end, ZenzeTech ended up as finalist in the program among five others after thorough due diligence in 12 disciplines and two investor pitches

After participating in 'SundVækst', a program designed to help SME's to sell products to the public sector in Denmark, e.g. hospitals, the program financed a Freedom to Operate analysis and GDPR compliance process

After pitching in Paris, ZenzeTech was chosen as one of 10 Life Science and Medtech startups in Europe to participate in 'Neighborhood' 2022, a one-year regulatory development program

ZenzeTech secures financing from business angels with MedTech and Life Science experience to help with advice and further development.
Further finance was secured from The Danish Innovation Fund

ZenzeTech was awarded with a grant from Sportgoodsfonden for being one of three of the most promising startups in DTU Science Park with a scalable product and big potential to create an impact on patients worldwide
QUOTES
WHAT OTHERS SAY ABOUT US

The idea of an insole providing data is good, it is a simple solution for the patient and neurologist to understand. ZenzeTech is addressing a big problem and therefor a big market.

The insoles can be a tremendous help since we get continuous patient data, which a clinician can use for making medical decisions […] It is all about constantly regulating the balance of the medical treatment, which has huge effect on this patient group […] I think this makes perfect sense and I cannot see how we can do without it.

It is very important for me to trust the team. Christian and Magdalena possess a high degree of credibility, are transparent and honest which creates trust while they have the competencies to succeed.

Two key elements came into play when I invested in ZenzeTech – team and technology trends. I was impressed by the team behind ZenzeTech, they appeared trustworthy, calm, and composed with a good vision.

I think it is a very good idea since it is exactly gait that you are measuring […] the hospital is an artificial environment, but we would like a picture of how it is going at home.
SELECTED PARTNERs







LATEST NEWS
ZenzeTech is one of the most promising startups in DTU Science Park and receives grant Written by Christian Bygballe Haahr, May 9 …